🔎 Trials Near Me

Home › Schizophrenia › Massachusetts › Boston

Pag-aaral pangklinika para sa Schizophrenia sa Boston, MA

14 pag-aaral para sa Schizophrenia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Boston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

Nagre-recruitPhase 3
  • Boston Children's Hospital, Boston
Edad 13 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07288567

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Nagre-recruitPhase 3
  • Boston Children's Hospital, Boston
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07424404

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Massachusetts General Hospital, Charlestown · 1 mi ang layo
Edad 18 hanggang 45 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06386588

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Nagre-recruitPhase 2
  • Clinical Site, Boston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT07459647

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Nagre-recruitObservasyonal na pag-aaral
  • Boston Medical Center, Boston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07101094

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Boston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07227818

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Nagre-recruitPhase 3
  • Neurocrine Clinical Site, Boston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07114874

Cerebellar Modulation of Cognition in Psychosis

Nagre-recruit
  • Beth Israel Deaconess Medical Center, Boston
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06107764

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Massachusetts General Hospital, Charlestown · 1 mi ang layo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT04940663

CLOZAPINE Response in Biotype-1

Nagre-recruitPhase 4
  • Beth Israel Deaconess Medical Center, Boston
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update May 11, 2026 · NCT04580134

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Nagre-recruitObservasyonal na pag-aaral
  • Beth Israel Deaconess Medical Center, Boston
Edad 18 hanggang 40 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT06740383

Enhanced Coordinated Specialty Care for Early Psychosis

Nagre-recruit
  • Massachusetts General Hospital FEPP Clinic, Boston
  • Boston Medical Center WRAP, Boston
Lahat ng edad · Lahat ng kasarian · Na-update Peb 27, 2026 · NCT06071858

Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
  • Massachusetts General Hospital, Boston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 10, 2025 · NCT04296604

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
  • Reviva site, Boston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Dis 19, 2024 · NCT05184335

Pag-aaral para sa Schizophrenia sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.